DE69430569T2 - Carbocyclischen deoxyguanosinanaloga zur behandlung von viralen infektionen - Google Patents

Carbocyclischen deoxyguanosinanaloga zur behandlung von viralen infektionen

Info

Publication number
DE69430569T2
DE69430569T2 DE69430569T DE69430569T DE69430569T2 DE 69430569 T2 DE69430569 T2 DE 69430569T2 DE 69430569 T DE69430569 T DE 69430569T DE 69430569 T DE69430569 T DE 69430569T DE 69430569 T2 DE69430569 T2 DE 69430569T2
Authority
DE
Germany
Prior art keywords
viral infections
treating viral
deoxyguanosine analog
carbocyclic
carbocyclic deoxyguanosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69430569T
Other languages
English (en)
Other versions
DE69430569D1 (de
Inventor
John A Montgomery
Secrist, Iii
L Lee Bennett
William B Parker
Y Fulmer Shealy
David I Scheer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SOUTHERN RES INST BIRMINGHAM
Southern Research Institute
Original Assignee
SOUTHERN RES INST BIRMINGHAM
Southern Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/020,220 external-priority patent/US6001840A/en
Application filed by SOUTHERN RES INST BIRMINGHAM, Southern Research Institute filed Critical SOUTHERN RES INST BIRMINGHAM
Publication of DE69430569D1 publication Critical patent/DE69430569D1/de
Application granted granted Critical
Publication of DE69430569T2 publication Critical patent/DE69430569T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69430569T 1993-02-19 1994-02-22 Carbocyclischen deoxyguanosinanaloga zur behandlung von viralen infektionen Expired - Fee Related DE69430569T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/020,220 US6001840A (en) 1990-03-06 1993-02-19 Methods of treatment of viral infections using carbocyclic deoxyguanosine analogs
PCT/US1994/001783 WO1994018979A2 (en) 1993-02-19 1994-02-22 Methods of treatment of viral infections using carbocyclic deoxyguanosine analogs

Publications (2)

Publication Number Publication Date
DE69430569D1 DE69430569D1 (de) 2002-06-13
DE69430569T2 true DE69430569T2 (de) 2002-10-31

Family

ID=21797398

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69430569T Expired - Fee Related DE69430569T2 (de) 1993-02-19 1994-02-22 Carbocyclischen deoxyguanosinanaloga zur behandlung von viralen infektionen

Country Status (3)

Country Link
EP (1) EP0684822B1 (de)
DE (1) DE69430569T2 (de)
WO (1) WO1994018979A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2793413B1 (fr) * 1999-05-10 2008-11-07 Centre Nat Rech Scient Utilisation d'analogues nucleotidiques agissant comme substrat de la reverse transcriptase pour le traitement des affections faisant intervenir la reverse-transcription

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8602346D0 (en) * 1986-01-30 1986-03-05 Wellcome Found Antiviral combinations
US4950758A (en) * 1988-01-20 1990-08-21 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
US5059690A (en) * 1990-03-01 1991-10-22 E. R. Squibb & Sons, Inc. Purinyl tetrahydrofurans

Also Published As

Publication number Publication date
EP0684822B1 (de) 2002-05-08
DE69430569D1 (de) 2002-06-13
WO1994018979A2 (en) 1994-09-01
EP0684822A4 (de) 1996-01-10
EP0684822A1 (de) 1995-12-06

Similar Documents

Publication Publication Date Title
DE69427869D1 (de) Botulinumtoxine zur behandlung von hyperhydrosis
DE69422575T2 (de) System zur Erklärung von Austellungsstücken
DE69323983T2 (de) Methode zur Modifizierung des Fettdruckes von Buchstaben
DE69524365T2 (de) Verfahren zur Isolierung und Reinigung von 2'-Deoxy-2',2'-difluornucleosiden
DE69421211D1 (de) System zur Abwasserbehandlung
DE69314962T2 (de) Verfahren zur entkeimung von lebensmitteln
DE69421196D1 (de) Vorrichtung zur behandlung von überbiss
DE69433793D1 (de) Phosphorderivate zur behandlung von aids
DE69130871D1 (de) Verfahren zur inaktivierung von spermien
DE69305411D1 (de) Verfahren zur Beseitigung von Mikroorganismen
DE59200262D1 (de) Verfahren zur Reinigung von Bisphenolen.
DE59206341D1 (de) Verfahren zur Reinigung von Organopolysiloxanen
DE69300901T2 (de) Verfahren zur Reinigung von 1,1,1,2-Tetrafluorethan.
DE69304687D1 (de) Verfahren zur Herstellung von Ethylbenzol
DE69204493D1 (de) Verfahren zur Reinigung von Dimethylcarbonat.
DE59204390D1 (de) Verfahren zur Reinigung von Indigo.
DE69406368D1 (de) Verfahren zur Herstellung von Nitroanilinderivaten
DE69430569D1 (de) Carbocyclischen deoxyguanosinanaloga zur behandlung von viralen infektionen
DE59404007D1 (de) Verfahren zur Aufbereitung von Altpapier
DE69203707D1 (de) Verfahren zur Reinigung von Fluorethanen und Chlorfluorethanen.
DE69109841D1 (de) Verfahren zur katalytischen Monoepoxidierung von Diolefinen.
DE69300712D1 (de) Verfahren zur Reinigung von L-Phenylalanin.
DE69300700D1 (de) Verfahren zur Lösung von 3-Dimethylamino-2-Methylpropiophenon (3-Damp).
DE69218093D1 (de) Verfahren zur Reinigung von 1,1,3,4,4,6-Hexamethyltetralin
DE69314086D1 (de) Verfahren zur Reinigung von 4,4'-Diaminodiphenylmethan

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee